دورية أكاديمية

Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial.

التفاصيل البيبلوغرافية
العنوان: Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial.
المؤلفون: Camenzind, Edoardo1, Wijns, William2, Mauri, Laura3, Kurowski, Volkhard4, Parikh, Keyur5, Runlin Gao5, Bode, Christoph6, Greenwood, John P.7, Boersma, Eric, Vranckx, Pascal8, McFadden, Eugene9, Serruys, Patrick W.8, WO'Neil, William10, Jorissen, Brenda, Van Leeuwen, Frank11, Steg, Ph. Gabriel12 Switzerlandedoardo@camenzind-cardio.net
المصدر: Lancet. 10/20/2012, Vol. 380 Issue 9851, p1396-1405. 10p.
مصطلحات موضوعية: *HEART diseases, *THERAPEUTICS, *SURGICAL anastomosis, *SURGICAL stents, *RANDOMIZED controlled trials, *SURGICAL emergencies, *CORONARY artery stenosis
مستخلص: The article focuses on a study conducted to compare the two treatment techniques for cardiac disorders including Endeavor zotarolimus-eluting stent (E-ZES) and Cypher sirolimus-eluting stent (C-SES). It informs that a randomized controlled trial was conducted on 8791 patients undergoing emergency surgery in native coronary arteries. The results have shown that no superiority difference was found between E-ZES and C-SES during the treatment. INSET: Panel: Research in context.
قاعدة البيانات: Academic Search Index
الوصف
تدمد:01406736
DOI:10.1016/S0140-6736(12)61336-1